NEW YORK (AP) _ Intercept Pharmaceuticals Inc. (ICPT) on Friday reported a loss of $17.3 million in its first quarter.On a per-share basis, the New York-based company said it had a loss of 58 cents.The results topped Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 89 cents per share.The drugmaker posted revenue of $88.6 million in the period, falling short of Street forecasts. Seven analysts surveyed by Zacks expected $90.9 million._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ICPT at https://www.zacks.com/ap/ICPT